Sie können so einfach wie möglich - CCRP bestehen!

Wiki Article

Laden Sie die neuesten ExamFragen CCRP PDF-Versionen von Prüfungsfragen kostenlos von Google Drive herunter: https://drive.google.com/open?id=1Svee_ruEO330sHr4tzojQjjLcZ8PVG2X

Die zielgerichteten Prüfungsfragen und Antworten zur SOCRA CCRP Zertifizierungsprüfung von ExamFragen sind sehr beliebt. Mit den Materialien von ExamFragen können Sie nicht nur neue Kenntnisse und Erfahrungen gewinnen, sondern sich auch genügend auf die Prüfung vorbereiten. Obwohl die SOCRA CCRP Zertifizierungsprüfung schwer ist, würden Sie mehr Selbewusstsein für die Prüfung haben, nachdem Sie diese Fragenkataloge gekauft haben. Wählen Sie die effizienten Fragenkataloge von ExamFragen ganz beruhigt, um sich genügend auf die SOCRA CCRP (Certified Clinical Research Professional (CCRP)) Zertifizierungsprüfung vorzubereiten.

Es ist eine weise Wahl, sich an der SOCRA CCRP Zertifizierungsprüfung zu beteiligen. Mit dem SOCRA CCRP Zertifikat werden Ihr Gehalt, Ihre Stelle und auch Ihre Lebensverhältnisse verbessert werden. Es ist doch nicht so einfach, die SOCRA CCRP Zertifizierungsprüfung zu bestehen. Sie nehmen viel Zeit und Energie in Anspruch, um Ihre Fachkenntnisse zu konsolidieren. ExamFragen ist eine spezielle Schulungswebsite, die Schulungsprogramme zur SOCRA CCRP (Certified Clinical Research Professional (CCRP)) Zertifizierungsprüfung bearbeiten. Sie können zuerst die Demo zur SOCRA CCRP Zertifizierungsprüfung im Internet als Probe kostenlos herunterladen, so dass Sie die Glaubwürdigkeit unserer Produkte testen können. Normalerweise werden Sie nach dem Probieren unserer Produkte Vertrauen in unsere Produkte haben.

>> CCRP Fragenkatalog <<

SOCRA CCRP Examsfragen - CCRP Prüfungsunterlagen

Unser ExamFragen gibt viele Mühe aus, um den Kandidaten den besten und effizienten Service zu bieten. Heutztage ist hohe Effizienz ein beliebtes Thema. So hat ExamFragen die effizienten Schulungsunterlagen für den Kandidaten entworfen, so dasss Sie die Kenntnisse über SOCRA CCRP Zertifizierung schnell meistern und gute Leistungen in der Prüfung erzielen. Die Schulungsunterlagen zur SOCRA CCRP Zertifizierungsprüfung von ExamFragen können den Kandidaten viel Zeit und Energie ersparen. Und die Kandidaten können deshalb mehr Geld verdienen.

SOCRA CCRP Prüfungsplan:

ThemaEinzelheiten
Thema 1
  • Research Study Closure: This section of the exam measures the skills of Clinical Research Coordinators and covers the activities required to properly conclude a clinical trial. It involves participating in the study closeout visit to verify documentation and account for the investigational product. The domain also includes developing and submitting final closure reports to the IRB, study sponsor, regulatory authorities, and clinicaltrials.gov. Finally, it covers the procedures for archiving study records.
Thema 2
  • Research Study Start-Up: This section of the exam measures the skills of Clinical Research Coordinators and covers the initial planning and setup of a clinical trial. It involves coordinating the development of the study protocol, ensuring it considers ethical guidelines and regulatory pathways like IND or IDE. It also includes creating essential study documents like informed consent forms and case report forms. The domain covers obtaining necessary approvals from stakeholders like the IRB and sponsor, selecting study sites, training staff, and ensuring the study's compliance with various laws. Additionally, it involves obtaining the research product and preparing all necessary tools and documentation for the study's commencement.|Research Study Implementation: This section of the exam measures the skills of Clinical Research Associates and covers the active management and execution of the clinical trial. It focuses on following the study protocol and standard operating procedures, managing the investigational product, and ensuring ongoing regulatory compliance. The domain includes identifying, documenting, and reporting any study anomalies such as adverse events or protocol deviations. It also involves managing subject recruitment, consent, and retention, as well as maintaining all study records and essential documents. Furthermore, it covers communicating with all study stakeholders and participating in study audits to ensure quality and adherence to regulations.

SOCRA Certified Clinical Research Professional (CCRP) CCRP Prüfungsfragen mit Lösungen (Q129-Q134):

129. Frage
In accordance with ICH, which of the following is an acceptable protocol review frequency for an IRB?

Antwort: A

Begründung:
IRBs must review protocols at least annually to ensure ongoing subject protection.
* 21 CFR 56.109(f):"An IRB shall conduct continuing review of research at intervals appropriate to the degree of risk, but not less than once per year."
* ICH E6(R2) 3.1.4:"The IRB/IEC should conduct continuing review of each ongoing trial at intervals appropriate to the degree of risk, but at least once per year." This establishes12 monthsas the minimum required interval. More frequent reviews (e.g., 6 months) may occur for higher-risk studies, but longer intervals (24-36 months) are not permitted.
Correct answer:B (12 months).
References:
21 CFR 56.109(f).
ICH E6(R2), §3.1.4.


130. Frage
In an IND study, the specified dosage of an investigational product is 2 mg twice a day for 10 days. The product is available in 1 mg tablets. The subject was given 45 tablets and was instructed to take 2 mg of the product twice a day for 10 days. How many tablets should the subject have after the 10 days?

Antwort: C

Begründung:
This question tests drug accountability and dosing calculation, which is central to ICH E6(R2) 4.6 (Investigational product management). Subjects must receive the correct supply and any discrepancy must be reconciled.
The prescribed regimen is 2 mg twice daily = 4 mg per day. With 1 mg tablets, this equals 4 tablets daily.
Over 10 days, the subject should consume 40 tablets (4 × 10 = 40). Since 45 tablets were dispensed, the subject should have 5 tablets remaining after 10 days.
Accurate accountability ensures trial integrity and subject safety. Investigators are responsible for maintaining investigational product (IP) records, including dispensing, usage, and returns. According to ICH:
4.6.3: "The investigator/institution should maintain records of the product's delivery to the trial site, the inventory, the use by each subject, and the return to the sponsor or alternative disposition."
4.6.5: "The investigator should ensure that investigational products are used only in accordance with the approved protocol." Thus, the correct answer is C (5 tablets remain). This reflects proper dosing compliance and highlights the importance of meticulous IP tracking in clinical trials.
References:
ICH E6(R2), §4.6 (Investigational Product(s)).


131. Frage
In accordance with 45 CFR 46, in addition to the Office for Human Research Protections (OHRP), a suspension of IRB/IEC approval must be reported to which of the following?

Antwort: A

Begründung:
If IRB/IEC approval is suspended or terminated, reporting is required to protect oversight and accountability.
* 45 CFR 46.113:"An IRB shall notify theinstitutional officials, the department or agency head, and OHRP(when applicable) of any suspension or termination of IRB approval." This ensures transparency and institutional responsibility for compliance. Internal hospital committees or directors (A, C, D) are not mandated reporting entities.
Thus, the correct answer isB (Appropriate institutional officials).
References:
45 CFR 46.113 (Suspension or termination of IRB approval).


132. Frage
In accordance with the CFR, clinical trial sponsors are required to retain records and reports after a marketing application is approved for at least:

Antwort: D

Begründung:
TheFDA record retention requirementfor investigational drug studies is clearly outlined in21 CFR 312.57 (c)and21 CFR 312.62(c).
* 21 CFR 312.57(c):"A sponsor shall retain the records and reports... for2 years after a marketing application is approvedfor the drug; or, if an application is not approved, until 2 years after shipment and delivery of the drug for investigational use is discontinued and FDA has been so notified."
* 21 CFR 312.62(c):Investigators also must retain study-related records for2 years following the date a marketing application is approvedor 2 years after the investigation is discontinued.
This requirement ensures FDA can audit investigational product data even after approval to confirm compliance and verify trial results. Longer retention (e.g., 15 years) may be institutional or sponsor policy but is not mandated by federal law.
Thus, the correct answer isA (2 years).
References:
21 CFR 312.57(c) (Sponsor record retention).
21 CFR 312.62(c) (Investigator record retention).


133. Frage
What is included in the Statement of Investigator (Form FDA 1572)?

Antwort: A

Begründung:
FormFDA 1572is the investigator's signed agreement to follow regulations.
* 21 CFR 312.53(c)(1)(vi)(c):Requires investigators to sign Form 1572, committing to conduct trials in accordance withFDA regulations (21 CFR 50 & 56).
* The form includes commitments to personally supervise, obtain informed consent, maintain records, and permit FDA inspections.
It does not include financial disclosures (covered under21 CFR 54) or preclinical data (in theIB).
References:21 CFR 312.53(c)(1)(vi)(c).


134. Frage
......

Wir versprechen, dass Sie die Prüfung zum ersten Mal mit unseren Schulungsunterlagen zur SOCRA CCRP Zertifizierungsprüfung bestehen können. Sonst erstatten wir Ihen die gesammte Summe zurück.

CCRP Examsfragen: https://www.examfragen.de/CCRP-pruefung-fragen.html

P.S. Kostenlose und neue CCRP Prüfungsfragen sind auf Google Drive freigegeben von ExamFragen verfügbar: https://drive.google.com/open?id=1Svee_ruEO330sHr4tzojQjjLcZ8PVG2X

Report this wiki page